DUQUESNE FAMILY OFFICE LLC – Alnylam Pharmaceuticals, Inc. Transaction History
DUQUESNE FAMILY OFFICE LLC portfolio value:
$17.79M
portfolio value
Alnylam Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | 0.00% | 88.91K shares | 17.79M | $200.16 | 88.91K |
| Q2 2022 | share | Decrease | -100.00% | -63.94K shares | -10.44M | $145.85 | 0 |
| Q1 2022 | share | Increase | 0.00% | 63.94K shares | 10.44M | $163.29 | 63.94K |
| Q4 2020 | share | Decrease | -100.00% | -368.41K shares | -53.64M | $129.97 | 0 |
| Q3 2020 | share | 0.00% | 0 shares | -925K | $145.6 | 368.41K | |
| Q2 2020 | share | 0.00% | 0 shares | 14.46M | $148.11 | 368.41K | |
| Q1 2020 | share | Increase | +217.14% | 252.25K shares | 26.72M | $108.85 | 368.41K |
| Q4 2019 | share | Increase | 0.00% | 116.16K shares | 13.37M | $115.17 | 116.16K |